- OACB Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Oaktree Acquisition Corp II (OACB) 8-K6 Apr 22Upon launch, HUKYNDRA® will be one of two citrate-free, high-concentration adalimumab biosimilars on the European marketFinancial data
Company Profile